News
We recently published 10 Big Names Bleed Double Digits. Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) is one of the ...
I think that's the case with Vertex. Here are seven reasons why Vertex is a no-brainer stock to buy on the dip.
20h
Clinical Trials Arena on MSNVertex’s Journavx successor culled after falling short in Phase II trialTopline results reveal that VX-993 did not meet its primary endpoints, meaning Vertex will discontinue its development.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results